● Round also saw participation from notable investors including Samir Singh, EVP - Asia, Colgate Palmolive & Former Chair of Unilever SE Asia, Shuchi Kothari, Head of DSP Family Office and SRF Limited ● Company turned profitable in Q2 FY24-25 and crossed Rs. 100 Cr net revenue ARR in Q3 ● Company aims to clock Rs. 150 Cr net revenue ARR in the next quarter. ● Funds raised will be deployed for retail expansion and new product introduction across key channels ...
The move aims to strengthen EyeYon’s presence in Asia and enhance access to its innovative ophthalmic solutions....
Susvimo becomes the only FDA-approved therapy offering continuous drug delivery for diabetic eye disease....
World’s first pin-less, image-less solution for precise acetabular cup positioning in anterior hip arthroplasty....
Successful results from the pivotal study pave the way for regulatory submissions in lung cancer screening....
The enhanced system now supports multiple languages, improving accessibility for global drug screening operations....
The partnership aims to make QR678®'s advanced, non-surgical hair regrowth treatment more accessible across the country through Spectra Medical’s distribution network. ...
JOURNAVX™ introduces a first-in-class approach to managing moderate-to-severe acute pain, offering an alternative to traditional opioid therapies....
The latest updates on the market rollout of Ryoncil® and insights into the company’s expanding pipeline of innovative therapies....
The funding will help scale access to telehealth-based opioid use disorder care across the U.S., improving patient reach and support....